Similar Items: Novel therapeutic agents that blunt hyperglycemia-induced cardiac contractile dysfunction
- Proteasome Inhibitors : a novel therapy that blunt hyperglycemia-induced cardiac contractile dysfunction
- Hyperglycemia-mediated onset of myocardial insulin resistance – unraveling molecular mechanisms and identifying therapeutic targets
- Increased hexosamine biosynthetic pathway flux impairs myocardial GLUT4 translocation
- Endothelial dysfunction in cardiac microvascular endothelial cells : an investigation into cellular mechanisms and putative role of oleanolic acid in reversing endothelial dysfunction
- Elucidating the underlying mechanisms of benfotiamine-induced cardioprotection
- A study of the early changes in hearts from diet-induced obese rats that may lead to cardiac dysfunction
Author: Essop, M. Faadiel
- TKTL1 plays a critical role in ameliorating intracellular oxidative stress under hyperglycemic conditions
- Establishing a rodent model of long-term consumption of sugar-sweetened beverages
- Leukocyte O-GlcNAcylation : a novel diagnostic tool for the earlier detection of type 2 diabetes mellitus?
- Establishing and validating an in vivo rodent model of chronic restraint stress
- Elucidating the underlying mechanisms of benfotiamine-induced cardioprotection
- Novel therapeutic agents that blunt hyperglycemia-induced cardiac contractile dysfunction